Telesis Bio's market cap is currently ―. The company's EPS TTM is $-1.64; its P/E ratio is -0.27; Telesis Bio is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $-0.23. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22
Income Statement	-
Total Revenue	$ 8.65M	$ 6.32M	$ 9.47M	$ 6.67M	$ 5.66M
Gross Profit	$ 5.69M	$ 3.51M	$ 6.45M	$ 3.66M	$ 2.71M
EBIT	$ -8.28M	$ -10.87M	$ -7.88M	$ -11.99M	$ -14.53M
EBITDA	-	$ -9.64M	$ -6.94M	$ -11.23M	$ -13.88M
Net Income Common Stockholders	$ -8.44M	$ -11.12M	$ 5.06M	$ -12.31M	$ -14.83M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 47.35M	$ 23.53M	$ 30.59M	$ 49.76M	$ 61.89M
Total Assets	$ 114.53M	$ 89.16M	$ 81.36M	$ 88.14M	$ 97.28M
Total Debt	$ 49.26M	$ 50.43M	$ 34.59M	$ 21.38M	$ 16.80M
Net Debt	$ 1.91M	$ 26.89M	$ 3.99M	$ -28.38M	$ -45.09M
Total Liabilities	$ 58.46M	$ 52.54M	$ 34.80M	$ 34.83M	$ 32.56M
Stockholders Equity	$ 27.92M	$ 36.62M	$ 46.56M	$ 53.31M	$ 64.72M
Cash Flow	-
Free Cash Flow	-	$ -11.65M	$ -6.40M	$ -15.49M	$ -15.21M
Operating Cash Flow	$ -10.30M	$ -11.18M	$ -5.64M	$ -15.10M	$ -12.35M
Investing Cash Flow	$ 6.85M	$ 4.12M	$ 11.21M	$ 13.72M	$ 2.94M
Financing Cash Flow	$ 26.70M	$ -20.00K	$ 108.00K	$ 4.01M	$ 331.00K

Currency in USD

Telesis Bio Earnings and Revenue History

Income Statement >

Telesis Bio Debt to Assets

Balance Sheet >

Telesis Bio Cash Flow

Cash Flow >

Telesis Bio Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing